Viral dsRNA Inhibitors Prevent Self-association and Autophosphorylation of PKR

Journal of Molecular Biology

Volumn 372, Issue 1, 2007, Pages 103-113

  McKenna, Sean A ^a   Lindhout, Darrin A ^a   Shimoike, Takashi ^a,b   Aitken, Colin Echeverría ^a   Puglisi, Joseph D ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

inhibition; kinase; PKR; RNA; virus

Indexed keywords

PROTEIN KINASE; PROTEIN PKR; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS RNA;

ARTICLE; AUTOPHOSPHORYLATION; DIMERIZATION; DNA VIRUS; EPSTEIN BARR VIRUS; HELA CELL; HUMAN ADENOVIRUS; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RNA BINDING;

DNA VIRUSES; EUKARYOTA; HUMAN ADENOVIRUS;

EID: 34547676589     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2007.06.028     Document Type: Article

References (53)

1. Malmgaard L. Induction and regulation of IFNs during viral infections. J. Interferon Cytokine Res. 24 (2004) 439-454
2. Peel A.L. PKR activation in neurodegenerative disease. J. Neuropathol. Exp. Neurol. 63 (2004) 97-105
3. Langland J.O., Cameron J.M., Heck M.C., Jancovich J.K., and Jacobs B.L. Inhibition of PKR by RNA and DNA viruses. Virus Res. 119 (2006) 100-110
4. Gale Jr. M., and Katze M.G. Molecular mechanisms of interferon resistance mediated by viral-directed inhibition of PKR, the interferon-induced protein kinase. Pharmacol. Ther. 78 (1998) 29-46
5. Francois C., Duverlie G., Rebouillat D., Khorsi H., Castelain S., Blum H.E., et al. Expression of hepatitis C virus proteins interferes with the antiviral action of interferon independently of PKR-mediated control of protein synthesis. J. Virol. 74 (2000) 5587-5596
6. Dever T.E. Gene-specific regulation by general translation factors. Cell 108 (2002) 545-556
7. Clemens M.J. PKR-a protein kinase regulated by double-stranded RNA. Int. J. Biochem. Cell Biol. 29 (1997) 945-959
8. Clemens M.J., and Elia A. The double-stranded RNA-dependent protein kinase PKR: structure and function. J. Interferon Cytokine Res. 17 (1997) 503-524
9. Nanduri S., Carpick B.W., Yang Y., Williams B.R., and Qin J. Structure of the double-stranded RNA-binding domain of the protein kinase PKR reveals the molecular basis of its dsRNA-mediated activation. EMBO J. 17 (1998) 5458-5465
10. McKenna S.A., Kim I., Liu C.W., and Puglisi J.D. Uncoupling of RNA binding and PKR kinase activation by viral inhibitor RNAs. J. Mol. Biol. 358 (2006) 1270-1285
11. McCormack S.J., Ortega L.G., Doohan J.P., and Samuel C.E. Mechanism of interferon action motif I of the interferon-induced, RNA-dependent protein kinase (PKR) is sufficient to mediate RNA-binding activity. Virology 198 (1994) 92-99
12. McKenna S.A., Lindhout D.A., Kim I., Liu C.W., Gelev V.M., Wagner G., and Puglisi J.D. Molecular framework for the activaiton of PKR. J. Biol. Chem. 285 (2007) 11474-11486
13. Dey M., Cao C., Dar A.C., Tamura T., Ozato K., Sicheri F., and Dever T.E. Mechanistic link between PKR dimerization, autophosphorylation, and eIF2alpha substrate recognition. Cell 122 (2005) 901-913
14. Taylor S.S., Haste N.M., and Ghosh G. PKR and eIF2alpha: integration of kinase dimerization, activation, and substrate docking. Cell 122 (2005) 823-825
15. Dar A.C., Dever T.E., and Sicheri F. Higher-order substrate recognition of eIF2alpha by the RNA-dependent protein kinase PKR. Cell 122 (2005) 887-900
16. Lemaire P.A., Tessmer I., Craig R., Erie D.A., and Cole J.L. Unactivated PKR exists in an open conformation capable of binding nucleotides. Biochemistry 45 (2006) 9074-9084
17. Romano P.R., Garcia-Barrio M.T., Zhang X., Wang Q., Taylor D.R., Zhang F., et al. Autophosphorylation in the activation loop is required for full kinase activity in vivo of human and yeast eukaryotic initiation factor 2alpha kinases PKR and GCN2. Mol. Cell. Biol. 18 (1998) 2282-2297
18. Taylor D.R., Lee S.B., Romano P.R., Marshak D.R., Hinnebusch A.G., Esteban M., and Mathews M.B. Autophosphorylation sites participate in the activation of the double-stranded-RNA-activated protein kinase PKR. Mol. Cell. Biol. 16 (1996) 6295-6302
19. Lemaire P.A., Lary J., and Cole J.L. Mechanism of PKR activation: dimerization and kinase activation in the absence of double-stranded RNA. J. Mol. Biol. 345 (2005) 81-90
20. Vattem K.M., Staschke K.A., and Wek R.C. Mechanism of activation of the double-stranded-RNA-dependent protein kinase, PKR: role of dimerization and cellular localization in the stimulation of PKR phosphorylation of eukaryotic initiation factor-2 (eIF2). Eur. J. Biochem. 268 (2001) 3674-3684
21. Wu S., and Kaufman R.J. A model for the double-stranded RNA (dsRNA)-dependent dimerization and activation of the dsRNA-activated protein kinase PKR. J. Biol. Chem. 272 (1997) 1291-1296
22. Jammi N.V., and Beal P.A. Phosphorylation of the RNA-dependent protein kinase regulates its RNA-binding activity. Nucl. Acids Res. 29 (2001) 3020-3029
23. Ramos A., Grunert S., Adams J., Micklem D.R., Proctor M.R., Freund S., et al. RNA recognition by a Staufen double-stranded RNA-binding domain. EMBO J. 19 (2000) 997-1009
24. Wu H., Henras A., Chanfreau G., and Feigon J. Structural basis for recognition of the AGNN tetraloop RNA fold by the double-stranded RNA-binding domain of Rnt1p RNase III. Proc. Natl Acad. Sci. USA 101 (2004) 8307-8312
25. Ryter J.M., and Schultz S.C. Molecular basis of double-stranded RNA-protein interactions: structure of a dsRNA-binding domain complexed with dsRNA. EMBO J. 17 (1998) 7505-7513
26. Ben-Asouli Y., Banai Y., Pel-Or Y., Shir A., and Kaempfer R. Human interferon-gamma mRNA autoregulates its translation through a pseudoknot that activates the interferon-inducible protein kinase PKR. Cell 108 (2002) 221-232
27. Osman F., Jarrous N., Ben-Asouli Y., and Kaempfer R. A cis-acting element in the 3′-untranslated region of human TNF-alpha mRNA renders splicing dependent on the activation of protein kinase PKR. Genes Dev. 13 (1999) 3280-3293
28. Vuyisich M., Spanggord R.J., and Beal P.A. The binding site of the RNA-dependent protein kinase (PKR) on EBER1 RNA from Epstein-Barr virus. EMBO Rep. 3 (2002) 622-627
29. Bommer U.A., Borovjagin A.V., Greagg M.A., Jeffrey I.W., Russell P., Laing K.G., et al. The mRNA of the translationally controlled tumor protein P23/TCTP is a highly structured RNA, which activates the dsRNA-dependent protein kinase PKR. RNA 8 (2002) 478-496
30. Spanggord R.J., and Beal P.A. Selective binding by the RNA binding domain of PKR revealed by affinity cleavage. Biochemistry 40 (2001) 4272-4280
31. Maitra R.K., McMillan N.A., Desai S., McSwiggen J., Hovanessian A.G., Sen G., et al. HIV-1 TAR RNA has an intrinsic ability to activate interferon-inducible enzymes. Virology 204 (1994) 823-827
32. Kim I., Liu C.W., and Puglisi J.D. Specific recognition of HIV TAR RNA by the dsRNA binding domains (dsRBD1-dsRBD2) of PKR. J. Mol. Biol. 358 (2006) 430-442
33. Bevilacqua P.C., and Cech T.R. Minor-groove recognition of double-stranded RNA by the double-stranded RNA-binding domain from the RNA-activated protein kinase PKR. Biochemistry 35 (1996) 9983-9994
34. Robertson H.D., and Mathews M.B. The regulation of the protein kinase PKR by RNA. Biochimie 78 (1996) 909-914
35. Kumar K.U., Srivastava S.P., and Kaufman R.J. Double-stranded RNA-activated protein kinase (PKR) is negatively regulated by 60S ribosomal subunit protein L18. Mol. Cell. Biol. 19 (1999) 1116-1125
36. Sharp T.V., Schwemmle M., Jeffrey I., Laing K., Mellor H., Proud C.G., et al. Comparative analysis of the regulation of the interferon-inducible protein kinase PKR by Epstein-Barr virus RNAs EBER-1 and EBER-2 and adenovirus VAI RNA. Nucl. Acids Res. 21 (1993) 4483-4490
37. Ghadge G.D., Malhotra P., Furtado M.R., Dhar R., and Thimmapaya B. In vitro analysis of virus-associated RNA I (VAI RNA): inhibition of the double-stranded RNA-activated protein kinase PKR by VAI RNA mutants correlates with the in vivo phenotype and the structural integrity of the central domain. J. Virol. 68 (1994) 4137-4151
38. Clarke P.A., Schwemmle M., Schickinger J., Hilse K., and Clemens M.J. Binding of Epstein-Barr virus small RNA EBER-1 to the double-stranded RNA-activated protein kinase DAI. Nucl. Acids Res. 19 (1991) 243-248
39. Kitajewski J., Schneider R.J., Safer B., Munemitsu S. M., Samuel C.E., Thimmappaya B., and Shenk T. Adenovirus VAI RNA antagonizes the antiviral action of interferon by preventing activation of the interferon-induced eIF-2 alpha kinase. Cell 45 (1986) 195-200
40. Clarke P.A., and Mathews M.B. Interactions between the double-stranded RNA binding motif and RNA: definition of the binding site for the interferon-induced protein kinase DAI (PKR) on adenovirus VA RNA. RNA 1 (1995) 7-20
41. Mellits K.H., Kostura M., and Mathews M.B. Interaction of adenovirus VA RNAl with the protein kinase DAI: nonequivalence of binding and function. Cell 61 (1990) 843-852
42. Ma Y., and Mathews M.B. Structure, function, and evolution of adenovirus-associated RNA: a phylogenetic approach. J. Virol. 70 (1996) 5083-5099
43. Gabel F., Wang D., Madern D., Sadler A., Dayie K., Daryoush M.Z., et al. Dynamic flexibility of double-stranded RNA activated PKR in solution. J. Mol. Biol. 359 (2006) 610-623
44. Wu S., and Kaufman R.J. trans-Autophosphorylation by the isolated kinase domain is not sufficient for dimerization or activation of the dsRNA-activated protein kinase PKR. Biochemistry 43 (2004) 11027-11034
45. Sonenberg N., and Dever T.E. Eukaryotic translation initiation factors and regulators. Curr. Opin. Struct. Biol. 13 (2003) 56-63
46. Rahman A., Malhotra P., Dhar R., Kewalramani T., and Thimmapaya B. Effect of single-base substitutions in the central domain of virus-associated RNA I on its function. J. Virol. 69 (1995) 4299-4307
47. Mellits K.H., Pe'ery T., Manche L., Robertson H.D., and Mathews M.B. Removal of double-stranded contaminants from RNA transcripts: synthesis of adenovirus VA RNAI from a T7 vector. Nucl. Acids Res. 18 (1990) 5401-5406
48. Kim I., McKenna S.A., Puglisi E.V., and Puglisi J. D. Rapid purification of RNAs using fast performance liquid chromatography (FPLC). RNA 13 (2007) 1-6
49. Abramoff M.D., Magelhaes P.J., and Ram S.J. Image processing with ImageJ. Biophoton. Internat. 11 (2004) 36-42
50. Otto G.A., and Puglisi J.D. The pathway of HCV IRES-mediated translation initiation. Cell 119 (2004) 369-380
51. Clarke P.A., Pe'ery T., Ma Y., and Mathews M.B. Structural features of adenovirus 2 virus-associated RNA required for binding to the protein kinase DAI. Nucl. Acids Res. 22 (1994) 4364-4374
52. Glickman J.N., Howe J.G., and Steitz J.A. Structural analyses of EBER1 and EBER2 ribonucleoprotein particles present in Epstein-Barr virus-infected cells. J. Virol. 62 (1988) 902-911
53. Muesing M.A., Smith D.H., and Capon D.J. Regulation of mRNA accumulation by a human immunodeficiency virus trans-activator protein. Cell 48 (1987) 691-701